Literature DB >> 21272965

Anti-tubercular agents. Part 6: synthesis and antimycobacterial activity of novel arylsulfonamido conjugated oxazolidinones.

Ahmed Kamal1, Rajesh V C R N C Shetti, Shaik Azeeza, P Swapna, M Naseer A Khan, Inshad Ali Khan, Sandeep Sharma, Sheikh Tasduq Abdullah.   

Abstract

As a part of investigation of new anti-tubercular agents in this laboratory, herein we describe the synthesis of a new class of arylsulfonamido conjugated oxazolidinones. The in vitro activity of these conjugated (6a-f, 7a-d, 9a-c and 11a-c) molecules against Mycobacterium tuberculosis H(37)Rv by using rifampicin and linezolide as positive controls is discussed, compounds 7c and 9a-c are found to be the most active members in this series. Further, cytotoxicity of the potent conjugates of the series (7c, and 9a-c) was evaluated on human foreskin fibroblast (HFF) cells by using MTT assay. Finally, these studies suggest that compounds 7c and 9a may serve as promising lead scaffolds for further generation of new as anti-TB agents.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21272965     DOI: 10.1016/j.ejmech.2010.12.028

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  2 in total

1.  Synthesis and biological activity of novel 3-heteroaryl-2H-pyrido[4,3-e][1,2,4]thiadiazine and 3-heteroaryl-2H-benzo[e][1,2,4]thiadiazine 1,1-dioxides.

Authors:  Katarzyna Gobis; Henryk Foks; Jarosłw Sławiński; Ewa Augustynowicz-Kopeć; Agnieszka Napiórkowska
Journal:  Monatsh Chem       Date:  2013-05-14       Impact factor: 1.451

2.  Synthesis, in silico study (DFT, ADMET) and crystal structure of novel sulfamoyloxy-oxazolidinones: Interaction with SARS-CoV-2.

Authors:  Abdeslem Bouzina; Malika Berredjem; Sofiane Bouacida; Khaldoun Bachari; Christelle Marminon; Marc Le Borgne; Zouhair Bouaziz; Yousra Ouafa Bouone
Journal:  J Mol Struct       Date:  2022-02-05       Impact factor: 3.841

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.